Hospira has joined the Generic Pharmaceutical Association (GPhA). Hospira’s specialty injectable pharmaceuticals (SIP) offering includes approximately 200 generic injectable drugs in many dosages and formulations. Therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, emergency and other areas. Hospira also has pipelines of both generic and biosimilar drugs. “Hospira is pleased to announce our membership in the GPhA,” said Thomas Moore, president, U.S., Hosp...